{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:49:48Z","timestamp":1791308988736,"version":"4.3.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/inf.0b013e31825d2fa2","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T15:24:18Z","timestamp":1337873058000},"page":"935-937","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacokinetics and Tolerability of Single-Dose Daptomycin in Young Infants"],"prefix":"10.1097","volume":"31","author":[{"given":"Michael","family":"Cohen-Wolkowiez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"F365","DOI":"10.1136\/adc.2010.196402","article-title":"Vancomycin prescription in neonates and young infants: toward a simplified dosage.","volume":"96","author":"Oudin","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.jp.7211898","article-title":"Daptomycin use in infants: report of two cases with peak and trough drug concentrations.","volume":"28","author":"Cohen-Wolkowiez","year":"2008","journal-title":"J Perinatol"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/INF.0b013e318160edfc","article-title":"Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.","volume":"27","author":"Abdel-Rahman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/0091270004265646","article-title":"Single-dose pharmacokinetics of daptomycin in young and geriatric volunteers.","volume":"44","author":"Dvorchik","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.48.8.2799-2807.2004","article-title":"Population pharmacokinetics of daptomycin.","volume":"48","author":"Dvorchik","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/0091270004266619","article-title":"Moderate liver impairment has no influence on daptomycin pharmacokinetics.","volume":"44","author":"Dvorchik","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cbi.2004.08.004","article-title":"An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes.","volume":"150","author":"Oleson","year":"2004","journal-title":"Chem Biol Interact"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00128072-200103100-00003","article-title":"Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.","volume":"3","author":"Singh","year":"2001","journal-title":"Paediatr Drugs"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/INF.0b013e31820fc8e1","article-title":"Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mgkg in children aged 2 to 6 years with suspected or proved Gram-positive infections.","volume":"30","author":"Abdel-Rahman","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0029-1243370","article-title":"Daptomycin use in a neonate: serum level monitoring and outcome.","volume":"27","author":"Sarafidis","year":"2010","journal-title":"Am J Perinatol"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"Daptomycin 98-01 and 99-01 Investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201209000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:02:28Z","timestamp":1618034548000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201209000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31825d2fa2","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}